Status:
NOT_YET_RECRUITING
The Efficacy of Intralesional Bleomycin as Compared to 5-Flourouracil (5-FU) and Triamcinolone Acetonide (TAC) for the Treatment of Keloids: A Randomized Control Trial.
Lead Sponsor:
King Edward Medical University
Conditions:
Keloids Scars
Eligibility:
All Genders
13-60 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to learn if drug bleomycin intralesionally is beneficial than intralesional 5FU and Triamcinolone Acetonide in treating Keloids. The main questions it aims to answer...
Detailed Description
The goal of this clinical trial is to learn if drug bleomycin intralesionally is beneficial than intralesional 5FU and Triamcinolone Acetonide in treating Keloids. The main questions it aims to answer...
Eligibility Criteria
Inclusion
- All, patients aged 13-60 years of age, either gender enrolled for Keloid treatment under local anaesthesia.
Exclusion
- Allergic to bleomycin, 5-FU DIABETICS VASCULAR INSUFFICIENCY AT THE AFFECTED SITE
Key Trial Info
Start Date :
December 2 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 28 2026
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT07201766
Start Date
December 2 2025
End Date
February 28 2026
Last Update
November 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
King Edward Medical University
Lahore, Pakistan, 54000